Insilico Medicine

Insilico MedicineInsilico Medicine
Insilico Medicine

Insilico Medicine

A clinical-stage AI drug discovery company accelerating the development of novel therapeutics for various diseases.

DR 69Speed 502014Active285Hong Kong, China
Rate

About

Insilico Medicine is a generative AI company focused on transforming drug discovery and development. They utilize proprietary AI platforms like PandaOmics and Chemistry42 to discover novel therapeutic targets and generate new molecular structures, aiming to extend healthy productive longevity.
Frequently asked

What does Insilico Medicine do?

Insilico Medicine is a generative AI company focused on transforming drug discovery and development. They utilize proprietary AI platforms like PandaOmics and Chemistry42 to discover novel therapeutic targets and generate new molecular structures, aiming to extend healthy productive longevity.

What is Insilico Medicine's revenue?

StartupHub estimates Insilico Medicine's annual revenue at $56.9M (range $33.9M to $123.4M, 66% confidence), based on comparable companies in the sector.

Where is Insilico Medicine headquartered?

Insilico Medicine is headquartered in Hong Kong, China.

When was Insilico Medicine founded?

Insilico Medicine was founded in 2014.

What industry does Insilico Medicine operate in?

Insilico Medicine operates in Biotech, MedTech, Drug Discovery, AI Drug Discovery, Genomics, Clinical Trials.

How many employees does Insilico Medicine have?

Insilico Medicine has approximately 285 people on record.

HEADCOUNT
285
DOMAIN RATING
69
Comments

No comments yet. Be the first to share your take.